SIGMAR1 and early-onset autosomal dominant Alzheimer disease: Since the discovery of Sigmar1, alterations in the it’s function have been reported to associate with the development of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD).